Drug Type Prophylactic vaccine, mRNA vaccine |
Synonyms COVID-19 mRNA vaccine (Yale University), PACE-SARS-CoV-2 mRNA polyplexes (Yale University), XPACE 2001 + [1] |
Target |
Action inhibitors, stimulants |
Mechanism SARS-CoV-2 S protein inhibitors(SARS-CoV-2 S protein inhibitors), Immunostimulants |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
COVID-19 | Preclinical | United States | 16 Aug 2023 |